Results 1 to 10 of about 584 (139)

Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination

open access: yesCase Reports in Dermatological Medicine, 2022
SARS-CoV-2 vaccines were approved without long-term monitoring due to emergent situation and might have several side effects. Herein, we describe the first case with development of both LP and PV following COVID-19 vaccination.
Zeinab Aryanian   +4 more
doaj   +1 more source

Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy

open access: yesInternational Journal of Women's Dermatology, 2022
Background: . Rituximab (RTX) is an effective treatment for pemphigus; however, the drug labeling recommends not to use RTX within 1 year before conception. Objectives: .
Azin Dehghanimahmoudabadi, MD   +6 more
doaj   +1 more source

Coexistence of Neonatal Lupus Erythematous and Sturge–Weber Syndrome

open access: yesCase Reports in Dermatological Medicine, 2021
Neonatal lupus erythematous (NLE) is a rare condition presented by lupus dermatitis shortly after birth or later following sun exposure. Sturge–Weber syndrome (SWS) is also an uncommon congenital condition characterized by extensive capillary ...
Zahra Nikyar   +5 more
doaj   +1 more source

Pathophysiology of Autoimmune Bullous Diseases [PDF]

open access: yesJournal of Investigative Dermatology, 2008
In immunobullous disease, the host immune system disrupts adhesive interactions in the skin, typically leading to clinical blister formation. The pathophysiology of these diseases has been an active area of investigation. The mechanisms by which these disorders lead to loss of adhesion are variable and disease dependent; however, general principles ...
Liu, Zhi, Rubenstein, David S.
openaire   +3 more sources

Autoimmune bullous diseases

open access: yesAutoimmunity Reviews, 2011
Yaniv Sherer   +2 more
exaly   +3 more sources

An Unusual TEN-Like Presentation of Juvenile Bullous Pemphigoid: A Diagnostic Challenge

open access: yesCase Reports in Dermatological Medicine, 2022
Bullous pemphigoid (BP) is an acquired autoimmune bullous disorder rarely seen in the pediatric population. It usually presents as large and tense bullae, predominantly distributed in the acral areas.
Zahra Nikyar   +5 more
doaj   +1 more source

Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases

open access: yesClinical Case Reports, 2023
Key Clinical Message The immunosuppressant agents should be considered earlier in the course of treatment with rituximab, possibly after the unfavorable response at first cycle of treatment, especially in male patients and those with high BMI.
Zeinab Aryanian   +6 more
doaj   +1 more source

Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey

open access: yesCase Reports in Dermatology, 2022
Scleromyxedema is a rare but important mucinosis disorder of the skin that is presented with dermatological manifestations such as waxy papules, diffuse induration, and nondermatologic involvements like neurological and renal disorders.
Abtin Ansari   +6 more
doaj   +1 more source

Autoimmune Bullous Diseases in Childhood

open access: yes, 2022
Autoimmune bullous diseases (AIBDs) rarely occur in childhood and in contrast to the chronic disease course in adults, often have a milder clinical course, a better treatment response and better prognosis. Although literature is scarce, several case reports and case series describe childhood cases of linear IgA disease, bullous pemphigoid, dermatitis ...
Bolling, Maria C., Meijer, Joost M.
openaire   +2 more sources

Stigma Experience in Patients With Vitiligo: A Comprehensive Study in a Skin Hospital

open access: yesActa Medica Iranica, 2022
Vitiligo is the most common cause of skin depigmentation, which relates to a wide range of psychological disorders. Stigma is defined as a negative attitude towards oneself that results from one's perception of being different from the general ...
Ali Zare Dehnavi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy